BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: González-González R, López-Verdín S, Lavalle-Carrasco J, Molina-Frechero N, Isiordia-Espinoza M, Carreón-Burciaga RG, Bologna-Molina R. Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review. World J Clin Oncol 2020; 11(1): 31-42 [PMID: 31976308 DOI: 10.5306/wjco.v11.i1.31]
URL: https://www.wjgnet.com/2218-4333/full/v11/i1/31.htm
Number Citing Articles
1
Reinhard Buettner, Sibel Elif Gültekin. Molecular diagnostics in odontogenic tumorsDie Pathologie 2022; 43(S1): 81 doi: 10.1007/s00292-022-01152-7
2
Armin Nejat Dehkordi, Moein Maddahi, Parinaz Vafa, Nasim Ebrahimi, Amir Reza Aref. Salivary biomarkers: a promising approach for predicting immunotherapy response in head and neck cancersClinical and Translational Oncology 2024;  doi: 10.1007/s12094-024-03742-8
3
Hongyi Adrian Shi, Chee Wee Benjamin Ng, Chong Teck Kwa, Qiu Xia Chelsia Sim. Ameloblastoma: A succinct review of the classification, genetic understanding and novel molecular targeted therapiesThe Surgeon 2021; 19(4): 238 doi: 10.1016/j.surge.2020.06.009
4
Neda Kardouni Khoozestani, Farzaneh Mosavat, Mohammad Shirkhoda, Ramtin Azar, Leandro Napier de Souza. Ameloblastic Carcinoma with Calcification: A Rare Case Report in the Mandible and Literature ReviewCase Reports in Dentistry 2020; 2020: 1 doi: 10.1155/2020/4216489
5
Biswajit Jena, Sanjay Saxena, Gopal Krishna Nayak, Antonella Balestrieri, Neha Gupta, Narinder N. Khanna, John R. Laird, Manudeep K. Kalra, Mostafa M. Fouda, Luca Saba, Jasjit S. Suri. Brain Tumor Characterization Using Radiogenomics in Artificial Intelligence FrameworkCancers 2022; 14(16): 4052 doi: 10.3390/cancers14164052
6
Andy W. K. Yeung, Michael M. Bornstein. The Future Circle of HealthcareFuture of Business and Finance 2022; : 385 doi: 10.1007/978-3-030-99838-7_22
7
Nicholas E. Koutrakis, Daria Vasilyeva, Joel M. Friedman. Mandibular radiolucency in an 11-year-old girlThe Journal of the American Dental Association 2023; 154(6): 530 doi: 10.1016/j.adaj.2022.05.007
8
Monica B. Kowalski, Leib Y. Wiener, Daria Vasilyeva. Maxillary radiolucency in a 54-year-old manThe Journal of the American Dental Association 2024;  doi: 10.1016/j.adaj.2024.09.013
9
Arindam Malakar, V. Raj Kumar, Priya Yadav, Vishal Bhardwaj, Chuimee Gogoi Barua, Gourika Bhardwaj. The Role of BRAF Inhibitors in the Management of Ameloblastoma: A Literature ReviewCureus 2023;  doi: 10.7759/cureus.47682
10
Wen Li, Yang Li, Xiaoling Liu, Li Wang, Wenqian Chen, Xueshen Qian, Xianglong Zheng, Jiang Chen, Yiming Liu, Lisong Lin. Machine learning-based radiomics for predicting BRAF-V600E mutations in ameloblastomaFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1180908
11
Allan Vinícius Martins‐de‐Barros, Raíssa Soares dos Anjos, Caio César Gonçalves Silva, Emanuel Dias de Oliveira e Silva, Fábio Andrey da Costa Araújo, Marianne de Vasconcelos Carvalho. Diagnostic accuracy of immunohistochemistry compared with molecular tests for detection of BRAF V600E mutation in ameloblastomas: Systematic review and meta‐analysisJournal of Oral Pathology & Medicine 2022; 51(3): 223 doi: 10.1111/jop.13278
12
Gustavo de Souza Vieira, Pâmella de Pinho Montovani, Rafaela Elvira Rozza-de-Menezes, Karin Soares Gonçalves Cunha, Danielle Castex Conde. Comparative Analysis Between Dentinogenic Ghost Cell Tumor and Ghost Cell Odontogenic Carcinoma: A Systematic ReviewHead and Neck Pathology 2021; 15(4): 1265 doi: 10.1007/s12105-021-01347-z
13
Ashutosh Kumar Singh, Ragavi Alagarsamy, Rajib Chaulagain, Abanish Singh, Dipak Sapkota, Selvam Thavaraj, Rabindra P. Singh. Does BRAF mutation status and related clinicopathological factors affect the recurrence rate of ameloblastoma? A systematic review, meta‐analysis and metaregressionJournal of Oral Pathology & Medicine 2023; 52(10): 895 doi: 10.1111/jop.13494
14
Ramakant Dandriyal, Vishakha Lal, Kolli Yada Giri, Niranjanaprasad Indra Bavanthabettu, Archana Chaurasia, Swati Pant. Ameloblastoma: Retrospective Study and Analysis of 102 Cases Over 10 Years, Single Centre, Institutional ExperienceJournal of Maxillofacial and Oral Surgery 2022; 21(2): 730 doi: 10.1007/s12663-022-01694-6
15
Constanza Marin, Manas Dave, Keith D. Hunter. Malignant Odontogenic Tumours: A Systematic Review of Cases Reported in LiteratureFrontiers in Oral Health 2021; 2 doi: 10.3389/froh.2021.775707
16
Lucas Alves da Mota Santana, John Lennon Silva Cunha, Eduardo Morato de Oliveira, Mark John Santana Sabey, Erika Rezende‐Silva, Liane Maciel de Almeida Souza, Cleverson Luciano Trento. BRAFV600E expression in ameloblastomas: Report of two casesOral Surgery 2022; 15(3): 467 doi: 10.1111/ors.12586
17
Waheed Awotoye, Joseph Craig Whitt, Byunggil Yoo, Midhat S. Farooqi, Emily G. Farrow, Veerasathpurush Allareddy, Brad A. Amendt, Shankar Rengasamy Venugopalan. Genetic heterogeneity and enrichment of variants in DNA‐repair genes in ameloblastomaJournal of Oral Pathology & Medicine 2023; 52(3): 263 doi: 10.1111/jop.13410
18
X. Yang, K. Zhou, Y. Tao, S. Ge, W. Shang, K. Song. Treatment efficacy and prognosis of pulmonary metastasizing ameloblastoma: a systematic reviewInternational Journal of Oral and Maxillofacial Surgery 2022; 51(5): 579 doi: 10.1016/j.ijom.2021.07.016
19
Tara Renton, Vinod Patel. Oral surgery: what challenges and opportunities are there on the horizon?Dental Update 2023; 50(5): 422 doi: 10.12968/denu.2023.50.5.422
20
Lucrezia Togni, Antonio Zizzi, Roberta Mazzucchelli, Andrea Santarelli, Corrado Rubini, Marco Mascitti. Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysisInternational Journal of Oral Science 2022; 14(1) doi: 10.1038/s41368-022-00170-8
21
Bhaskar Narayan, Somesh Kumar, Priya Kumar, Aadithya B. Urs. “Is it time for personalised medicine for Ameloblastoma?”: A hypothesisJournal of Oral and Maxillofacial Pathology 2023; 27(4): 744 doi: 10.4103/jomfp.jomfp_356_23
22
Haiyang Li, Li Yang, Yali Hou, Yanning Zhang, Yunyi Cui, Xiangjun Li. Potential involvement of polycystins in the pathogenesis of ameloblastomas: Analysis based on bioinformatics and immunohistochemistryArchives of Oral Biology 2023; 149: 105662 doi: 10.1016/j.archoralbio.2023.105662
23
Zhao Zhang, Ye Peng, Jingyi Dang, Xincheng Liu, Dongze Zhu, Yushen Zhang, Yubo Shi, Hongbin Fan. Identification of key biomarkers related to epithelial‐mesenchymal transition and immune infiltration in ameloblastoma using integrated bioinformatics analysisOral Diseases 2023; 29(4): 1657 doi: 10.1111/odi.14173
24
Kanankira A. Nnko, Raphael T. Pima, Calvin Baraka, Enock A. Robi, Deogratius S. Rwakatema, Alex Mremi. Surgical management of mandibular ameloblastoma and immediate reconstruction with iliac crest and costochondrial bone grafts: A case reportInternational Journal of Surgery Case Reports 2024; 121: 110023 doi: 10.1016/j.ijscr.2024.110023
25
Anton Raemy, Laurence May, Nathalie Sala, Manuel Diezi, Maja Beck-Popovic, Martin Broome. Anti-MAPK Targeted Therapy for Ameloblastoma: Case Report with a Systematic ReviewCancers 2024; 16(12): 2174 doi: 10.3390/cancers16122174
26
Ao‐Bo Zhang, Jian‐Yun Zhang, Yu‐Ping Liu, Shuo Wang, Jia‐Ying Bai, Li‐Sha Sun, Tie‐Jun Li. Clinicopathological characteristics and diagnostic accuracy of BRAF mutations in ameloblastoma: A Bayesian network analysisJournal of Oral Pathology & Medicine 2024; 53(6): 393 doi: 10.1111/jop.13542
27
Konstantinos Kapriniotis, Angelina Bania, Savvas Lampridis, Georgios Geropoulos, Sofoklis Mitsos, Fleur Monk, David A. Moore, Nikolaos Panagiotopoulos. Metastatic mandibular ameloblastoma of the lung ten years after primary resection: A rare case reportMonaldi Archives for Chest Disease 2021; 91(2) doi: 10.4081/monaldi.2021.1643
28
Marilena Vered, John M. Wright. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Odontogenic and Maxillofacial Bone TumoursHead and Neck Pathology 2022; 16(1): 63 doi: 10.1007/s12105-021-01404-7
29
Hidenori Suzuki, Eiichi Sasaki, Ryota Nakamura, Michi Sawabe, Sumitaka Hagiwara, Ikuo Hyodo, Nobuhiro Hanai. Recurrent ameloblastoma with both hypercalcemia and BRAF mutation: A case reportClinical Case Reports 2020; 8(12): 3462 doi: 10.1002/ccr3.3443
30
Keith Hunter, Merva Soluk Tekkesin. Pathological Basis of Oral and Maxillofacial Diseases2025; : 585 doi: 10.1002/9781119989233.ch32
31
Rebeca Vieira Costa, Karolyny Martins Balbinot, Gabriela Cristina Avertano Rocha da Silveira, Maria Sueli da Silva Kataoka, Silvio Augusto Fernandes de Menezes, Vanessa Morais Freitas, Ana Carolina Uchoa Vasconcelos, Adriana Etges, Victor Angelo Martins Montalli, Fabricio Passador Santos, Sérgio de Melo Alves Júnior, Ruy Gastaldoni Jaeger, João de Jesus Viana Pinheiro. Prognostic value of the expression and localization of cell proliferation and apoptosis markers in unicystic ameloblastomasScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-54132-7
32
Alieh Farshbaf, Reza Zare, Farnaz Mohajertehran, Nooshin Mohtasham. New diagnostic molecular markers and biomarkers in odontogenic tumorsMolecular Biology Reports 2021; 48(4): 3617 doi: 10.1007/s11033-021-06286-0
33
Dragana Gabrić, Roko Bjelica, Mato Sušić, Marko Vuletić. Bone Tumours - A Comprehensive Review of Selected Topics2023;  doi: 10.5772/intechopen.107403
34
Yuichi EHARA, Koshuke NAGANAWA, Akira UKAI, Yuka MIYAMOTO, Kazuhiro WATANABE, Yasunori MURAMATSU. A case of ameloblastic carcinoma with BRAFV600E mutationJapanese Journal of Oral and Maxillofacial Surgery 2023; 69(4): 197 doi: 10.5794/jjoms.69.197
35
Allan Vinícius Martins‐de‐Barros, Caio César Gonçalves Silva, Kalyne Kelly Negromonte Gonçalves, Renata de Albuquerque Cavalcanti Almeida, Emanuel Dias de Oliveira e Silva, Fábio Andrey da Costa Araújo, Liam Robinson, Willie F. P. van Heerden, Marianne de Vasconcelos Carvalho. Does BRAF V600E mutation affect recurrence rate of ameloblastomas? Systematic review and meta‐analysisJournal of Oral Pathology & Medicine 2023; 52(8): 701 doi: 10.1111/jop.13458